Our results showed that PIMREG was overexpressed in many tumor types, including bladder urothelial carcinoma, bone cancer, cholangiocarcinoma, and glioblastoma multiforme (Fig. 1C). This evidence concerns the gene PIMREG and bladder transitional cell carcinoma.